Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption.
暂无分享,去创建一个
Remigijus Didziapetris | Pranas Japertas | Donatas Zmuidinavicius | Alex Avdeef | A. Avdeef | R. Didziapetris | Alanas Petrauskas | P. Japertas | A. Petrauskas | Donatas Zmuidinavicius
[1] A. Moffat,et al. Clarke's Isolation and identification of drugs in pharmaceuticals, body fluids, and post-mortem material , 1986 .
[2] L. Benet,et al. Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original artic , 1996 .
[3] F R Jelovsek,et al. Eliciting principles of hazard identification from experts. , 1990, Teratology.
[4] A. Dantzig,et al. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. , 1994, Biochimica et biophysica acta.
[5] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[6] Arun K Mandagere,et al. Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.
[7] C. Calhau,et al. Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[8] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[9] C. Tse,et al. Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells. , 1999, Biochimica et biophysica acta.
[10] A. Seelig. A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.
[11] R. Neubert,et al. Intestinal Transport of β-Lactam Antibiotics: Analysis of the Affinity at the H+/Peptide Symporter (PEPT1), the Uptake into Caco-2 Cell Monolayers and the Transepithelial Flux , 2004, Pharmaceutical Research.
[12] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[13] Thomas J. Raub,et al. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. , 1995, Journal of pharmaceutical sciences.
[14] G Houin,et al. Gastrointestinal absorption of drugs: methods and studies , 1999, Fundamental & Clinical Pharmacology.
[15] I. Rosenberg,et al. Carrier affinity as a mechanism for the pH-dependence of folate transport in the small intestine. , 1990, Biochimica et biophysica acta.
[16] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[17] H. Takanaga,et al. Transcellular Transport of Benzole Acid Across Caco-2 Cells by a pH-Dependent and Carrier-Mediated Transport Mechanism , 2004, Pharmaceutical Research.
[18] H. Koepsell,et al. Organic cation transporters in intestine, kidney, liver, and brain. , 1998, Annual review of physiology.
[19] J. Beijnen,et al. The pharmacological role of P-glycoprotein in the intestinal epithelium. , 1998, Pharmacological research.
[20] Christophe G. Lambert,et al. Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning , 1999, J. Chem. Inf. Comput. Sci..
[21] J. Blake,et al. Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules. , 2000, Current opinion in biotechnology.
[22] A. Leo,et al. Substituent constants for correlation analysis in chemistry and biology , 1979 .
[23] Y. Tsuda,et al. Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells. , 1999, The Journal of pharmacology and experimental therapeutics.
[24] A. Y. Lu,et al. Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.
[25] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[26] H. Takanaga,et al. pH‐Dependent and Carrier‐mediated Transport of Salicylic Acid Across Caco‐2 Cells , 1994, The Journal of pharmacy and pharmacology.
[27] Per Artursson,et al. Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.
[28] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[29] Hans Lennernäs,et al. Does Fluid Flow Across the Intestinal Mucosa Affect Quantitative Oral Drug Absorption? Is It Time for a Reevaluation? , 1995, Pharmaceutical Research.
[30] S. Rubin,et al. Transport of thiamine in human intestine: mechanism and regulation in intestinal epithelial cell model Caco-2. , 1999, American journal of physiology. Cell physiology.
[31] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[32] D K Yu,et al. The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions , 1999, Journal of clinical pharmacology.
[33] R L Lipnick. Correlative and mechanistic QSAR models in toxicology. , 1999, SAR and QSAR in environmental research.
[34] Remigijus Didziapetris,et al. Fragmental Methods in the Design of New Compounds. Applications of The Advanced Algorithm Builder , 2002 .
[35] Tudor I. Oprea,et al. Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.
[36] G. Koren,et al. Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance , 1997, Clinical pharmacokinetics.
[37] Xin Chen,et al. Recursive Partitioning Analysis of a Large Structure-Activity Data Set Using Three-Dimensional Descriptors1 , 1998, J. Chem. Inf. Comput. Sci..
[38] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[39] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[40] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[41] R. Neidlein,et al. In vitro Studies of Poorly Absorbed Drugs Using Porcine Intestine in the Ring Model RIMO , 2000, Arzneimittelforschung.
[42] J. Stein,et al. Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism , 2000, European journal of nutrition.
[43] B. H. Stewart,et al. Atorvastatin Transport in the Caco-2 Cell Model: Contributions of P-Glycoprotein and the Proton-Monocarboxylic Acid Co-Transporter , 2000, Pharmaceutical Research.
[44] Lawrence X. Yu,et al. Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.
[45] Xin Chen,et al. Automated Pharmacophore Identification for Large Chemical Data Sets1 , 1999, J. Chem. Inf. Comput. Sci..
[46] R. Lipnick. Outliers: their origin and use in the classification of molecular mechanisms of toxicity. , 1991, The Science of the total environment.
[47] James A. Platts,et al. Estimation of Molecular Linear Free Energy Relation Descriptors Using a Group Contribution Approach , 1999, J. Chem. Inf. Comput. Sci..
[48] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[49] H. Takanaga,et al. Stereoselective and Carrier-Mediated Transport of Monocarboxylic Acids Across Caco-2 Cells , 1996, Pharmaceutical Research.
[50] J. Delarue,et al. Mechanisms and kinetics of alpha-linolenic acid uptake in Caco-2 clone TC7. , 1997, Biochimica et biophysica acta.
[51] Thomas J. Raub,et al. Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. , 1994, Journal of pharmaceutical sciences.
[52] L. Benet,et al. Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.
[53] H. van de Waterbeemd,et al. Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.
[54] Kin-Kai Hwang,et al. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. , 2002, European journal of medicinal chemistry.
[55] A. Alex,et al. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. , 1999, Journal of medicinal chemistry.
[56] G Folkers,et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.